Skip to content
Basket0
Basket

Your basket is empty.

Your basket is empty.

view_cart
☰

Arcoxia

Arcoxia
In stock
60mg · 90mg · 120mg
from A$53.43
Strength
Pack size — the bigger the pack, the cheaper the tablet
A$64.11A$53.43
A$1.78 per tablet

In brief

  • Arcoxia (etoricoxib) is sold in pharmacies and by licensed suppliers; it is a prescription-only (Rx) medicine in Australia and most countries—although some pharmacies may at times supply it without a receipt, it should only be used under medical supervision and according to local law.
  • Arcoxia is used to treat osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute gouty arthritis and short‑term acute pain (including primary dysmenorrhoea and dental/postoperative pain). It is a COX‑2 selective non‑steroidal anti‑inflammatory drug (NSAID) that reduces pain and inflammation by selectively inhibiting the cyclooxygenase‑2 enzyme, lowering prostaglandin production.
  • Usual adult doses: osteoarthritis 60 mg once daily; rheumatoid arthritis and ankylosing spondylitis 90 mg once daily; acute gouty arthritis up to 120 mg once daily (max 8 days); acute pain and primary dysmenorrhoea 120 mg once daily short term (1–5 days); dental/postoperative pain 90–120 mg single dose or for 1–3 days. Use the lowest effective dose for the shortest duration.
  • Form of administration: oral film‑coated tablets (commonly 30 mg, 60 mg, 90 mg, 120 mg).
  • Onset time: rapid oral absorption with analgesic effect typically beginning within about 30–60 minutes.
  • Duration of action: effects generally last around 24 hours, allowing once‑daily dosing.
  • Alcohol warning: avoid heavy alcohol intake—alcohol can increase the risk of gastrointestinal bleeding, liver injury and worsening dizziness or drowsiness when taking Arcoxia.
  • The most common side effects are gastrointestinal upset such as dyspepsia and abdominal pain; other common reactions include headache, dizziness, peripheral oedema and mild increases in blood pressure.
  • Would you like to try arcoxia without a prescription?

Basic Arcoxia Information

  • INN (International Nonproprietary Name): Etoricoxib.
  • Brand Names Available In Australia: Arcoxia, Exinef, Nucoxia (brands listed in international packaging data; confirm local listing via TGA).
  • ATC Code: M01AH05.
  • Forms & Dosages: Film-coated tablets in 30 mg, 60 mg, 90 mg and 120 mg strengths; boxes and blister packs typically sold in 7, 14, 28 or 30 tablet counts.
  • Manufacturers In Australia: Not specified.
  • Registration Status In Australia: Not specified.
  • OTC / Rx Classification: Prescription only (Rx).

Critical Warnings And Restrictions

High-Risk Groups (Elderly, Pregnancy, Chronic Illness)

Arcoxia contains etoricoxib, a COX-2 selective NSAID with known cardiovascular and hepatic risks.

Patients with ischaemic heart disease, uncontrolled hypertension, cerebrovascular disease, peripheral arterial disease, congestive heart failure or a high cardiovascular risk profile should avoid Arcoxia unless the prescriber judges that benefits clearly outweigh risks.

Etoricoxib can affect liver function and renal perfusion in susceptible patients, so caution is required in liver or kidney disease.

  • Contraindications: hypersensitivity to etoricoxib or excipients.
  • Contraindications: history of NSAID-induced asthma, angioedema or severe allergy.
  • Contraindications: active or prior gastrointestinal bleeding or ulceration.
  • Contraindications: severe hepatic impairment.
  • Contraindications: creatinine clearance <30 mL/min.
  • Contraindications: pregnancy and lactation.
  • Contraindications: age <16 years.
  • Contraindications: concomitant use with other NSAIDs.

The elderly do not require automatic dose reduction, but they are at increased risk of cardiovascular and gastrointestinal adverse events and need closer monitoring.

  • Monitoring Checklist For Older Patients: blood pressure measurement.
  • Monitoring Checklist For Older Patients: renal function (serum creatinine and eGFR).
  • Monitoring Checklist For Older Patients: liver function tests (ALT, AST, bilirubin).
  • Monitoring Checklist For Older Patients: check for signs of peripheral oedema, sudden weight gain or breathlessness.
  • Pregnancy/Lactation — Why Contraindicated: risk of adverse foetal effects and potential bleeding at delivery.
  • Pregnancy/Lactation — Practical Point: avoid use in pregnancy and breastfeeding.
  • Patient Protection Actions: perform medication reconciliation before starting therapy.
  • Patient Protection Actions: obtain baseline blood pressure, renal function and liver function tests.
  • Patient Protection Actions: discuss cardiovascular and gastrointestinal warning signs with the patient.
  • Patient Protection Actions: provide a written patient card listing contraindications and emergency steps (stop medicine, seek urgent care for chest pain or black stools).

Interaction With Activities (Driving, Workplace Safety Under Australian Law)

Etoricoxib may cause dizziness or headache in some patients.

Patients must be cautioned about driving or operating heavy machinery until they know how the medicine affects them.

Employers and clinicians should note that under Australian work health and safety (WHS) law, any medication that impairs alertness may require workplace restrictions to protect others.

  • Symptoms To Watch: dizziness, drowsiness, blurred vision, light-headedness on standing.
  • Recommended Waiting Times: avoid driving or machinery until fully alert after the first dose or dose increase, typically 24 hours if symptoms occur.
  • Workplace Advice: disclose medication to occupational health if duties include heavy machinery, high-risk tasks or safety-sensitive roles.

Q&A — Can I Drive After Taking It In Australia?

Short answer: generally yes if you feel alert and free from dizziness or visual disturbance.

If you experience drowsiness, dizziness or orthostatic symptoms, do not drive or operate machinery.

Persistent or severe symptoms should be reported to your prescriber or pharmacist as they may indicate intolerance or an adverse effect requiring a dose change or stopping the medicine.

If you have a safety-sensitive job, speak to your GP or occupational health service before taking etoricoxib for the first time.

Usage Basics

INN, Brand Names Available In Australia

INN: etoricoxib.

Most commonly known internationally under the brand Arcoxia, manufactured by Merck/MSD.

  • Available Strengths: 30 mg, 60 mg, 90 mg, 120 mg film-coated tablets.
  • Packaging: boxes and blister packs in counts such as 7, 14, 28 or 30 tablets.
  • Other International Brands: Exinef, Nucoxia.

Clinicians should confirm local brand listings and formulations using the TGA ARTG and supplier records before prescribing or dispensing.

Legal Classification (TGA-Approved, PBS-Listed)

Etoricoxib is classified as prescription only (Rx) across markets according to product information.

In Australia, prescribing for a subsidised supply depends on PBS listing and authority criteria where applicable.

Check the TGA ARTG entry for current approval conditions and check the PBS schedule to confirm subsidy status and any authority requirements.

TGA Approval PBS Subsidy Status
Not specified Not specified

Dosing Guide

Standard Regimens (PBS Reference Dosing)

Indication Typical Adult Dose
Osteoarthritis 60 mg once daily
Rheumatoid Arthritis 90 mg once daily
Ankylosing Spondylitis 90 mg once daily
Acute Gouty Arthritis Up to 120 mg once daily (maximum 8 days)
Acute Pain / Primary Dysmenorrhoea 120 mg once daily (short term: 1–5 days)
Dental / Postoperative Pain 90–120 mg single dose or for 1–3 days

Always start at the lowest effective dose for the shortest possible duration.

Adjustments For Comorbidities

Children under 16 years: contraindicated.

Elderly patients: no routine dose change but monitor renal, hepatic and cardiac status closely.

Liver impairment:

  • Mild hepatic impairment: maximum 60 mg daily.
  • Moderate hepatic impairment: maximum 30 mg daily.
  • Severe hepatic impairment: contraindicated.

Renal impairment:

  • Severe renal impairment (CrCl <30 mL/min): contraindicated.
  • Mild to moderate renal impairment: monitor renal function closely; adjust therapy as clinically indicated.
  • Baseline Tests Checklist: BP, serum creatinine/eGFR, LFTs.
  • Dose Titration: begin at lowest effective strength and reassess within 1–4 weeks for tolerance and efficacy.
  • Follow-Up Frequency: recheck BP and renal function within 1–3 months in higher-risk patients, then periodically as clinically indicated.

Q&A — What If I Miss A Dose?

Take the missed dose as soon as you remember if there is adequate time before the next scheduled dose.

If it is close to the time of your next dose, skip the missed dose.

Do not double up to make up for a missed dose as this increases the risk of adverse effects.

If you have missed multiple doses or are unsure what to do, contact your pharmacist or GP for advice.

Interaction Chart

Food And Drinks (Alcohol, Coffee, Australian Diet Context)

Avoid heavy alcohol consumption while taking etoricoxib because alcohol increases the risk of gastrointestinal bleeding and may worsen blood pressure or liver strain.

Caffeine from coffee has no major direct pharmacokinetic interaction with etoricoxib, but it can exacerbate dyspepsia in sensitive individuals.

  • Limit alcohol intake while on treatment.
  • Take with food if you experience stomach upset.
  • Consider avoiding large quantities of irritating foods (very spicy or acidic) if dyspepsia occurs.

Common Drug Conflicts

Concomitant Drug Risk / Interaction Clinical Action
Anticoagulants / Antiplatelets Increased bleeding risk Review necessity, monitor INR, consult prescriber before starting
ACE Inhibitors / ARBs / Diuretics Reduced renal function and possible loss of BP control Monitor renal function and BP after initiation
Lithium Increased lithium plasma levels Monitor lithium concentrations closely
Methotrexate Increased methotrexate toxicity Monitor methotrexate levels and toxicity markers
SSRIs Higher risk of gastrointestinal bleeding Consider gastroprotection for high-risk patients
Other NSAIDs / High‑dose Aspirin Increased adverse effects; concurrent use contraindicated Avoid combination; use alternative analgesics
  • Clinical Actions Checklist: review all current medicines including OTCs and supplements.
  • Clinical Actions Checklist: consider temporary holds for interacting drugs when starting etoricoxib if appropriate.
  • Clinical Actions Checklist: monitor INR, creatinine and other relevant labs as indicated.

User Reports And Trends

Australian patients commonly leave feedback via ProductReview, HotDoc, health forums and during pharmacist consultations.

Typical comments report rapid pain relief in acute gout and dental pain with etoricoxib or Arcoxia 90 mg formulations.

  • Common Positives: effective for acute gout flares, good short-term relief for postoperative dental pain, quick onset of action noted by many users.
  • Common Complaints: dyspepsia, headache or dizziness in some patients, concerns about cost and prescription access.
  • Rural Vs Urban Trends: rural patients often prefer telehealth e-prescriptions and local pharmacy pickup; occasional stockouts of certain strengths reported in regional areas.
  • Pharmacist Actions: recommend gastroprotection where needed, counsel on CV risks, liaise with prescribers to adjust therapy or seek PBS options.

Anecdotal reports are useful for service improvement but should not replace clinical guidance.

Report suspected adverse events to the TGA’s adverse event reporting system.

Access And Purchase Options

National Chains (Chemist Warehouse, Priceline, TerryWhite Chemmart)

In Australia, Arcoxia and etoricoxib products require a prescription for legal supply.

Major chain pharmacies dispense prescriptions, offer price comparisons and click-and-collect services.

Chain Typical Service Price Check PBS Claim Availability
Chemist Warehouse In-store dispensing, click & collect Varies by location Varies / Check PBS schedule
Priceline In-store dispensing, price matching offers Varies by location Varies / Check PBS schedule
TerryWhite Chemmart Community pharmacy dispensing, in-store advice Varies by location Varies / Check PBS schedule

Online Pharmacies And Telehealth E-Prescriptions

Telehealth consultations can generate e-prescriptions for etoricoxib when clinically appropriate.

Online pharmacies will dispatch to metro and rural addresses but must verify a valid prescription before supply.

  • Safe Online Purchase Checklist: verify the prescriber is AHPRA-registered.
  • Safe Online Purchase Checklist: confirm the product is TGA-listed or locally supplied.
  • Safe Online Purchase Checklist: ensure pharmacist contact details are available for counselling.

In our online pharmacy, arcoxia is available without a prescription, with discreet delivery to Australia in 9-21 days.

Mechanism And Pharmacology

Simplified Explanation

Etoricoxib is a COX-2 selective inhibitor (ATC M01AH05) that reduces prostaglandin synthesis at sites of inflammation.

This action produces analgesic and anti-inflammatory effects while causing less inhibition of gastric COX-1 than many non-selective NSAIDs.

  • COX-1 Role: protects gastric mucosa and supports platelet function.
  • COX-2 Role: mediates inflammation and pain at injured tissues.

Rapid oral absorption provides relatively quick symptomatic relief in acute pain settings.

Clinical Terms

  • Pharmacokinetics Highlights: oral film-coated tablets in 30/60/90/120 mg strengths; rapid absorption supports fast onset of analgesia.
  • Pharmacodynamics Safety Points: COX-2 selectivity is associated with reduced gastric toxicity in many patients but carries an increased cardiovascular risk with prolonged or high-dose therapy.

Indications And Off-Label Uses

Approved Indications By TGA

Consult the product label and TGA ARTG for the definitive, locally approved indications.

Internationally common approved indications include osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute gouty arthritis, acute pain including primary dysmenorrhoea, and dental/postoperative pain.

PBS subsidy may restrict subsidised use to specified indications and doses.

Off-Label Uses In Australian Clinical Practice

Off-label use should be evidence-based, documented and discussed with the patient.

  • Examples include short-term management of severe musculoskeletal pain where alternatives are unsuitable.
  • Another scenario is acute postoperative pain when prescribed by a surgeon with a clear plan for duration.
  • Off-Label Checklist: document indication, intended duration and monitoring plan; obtain and record patient consent.

Key Clinical Findings

  • Efficacy Highlights: COX-2 inhibitors including etoricoxib provide effective pain relief comparable or superior to some non-selective NSAIDs for certain conditions.
  • GI Safety: etoricoxib generally causes fewer gastrointestinal ulcer events than some non-selective NSAIDs in clinical comparisons.
  • Cardiovascular Signals: increased cardiovascular risk remains a concern with long-term or high-dose COX-2 inhibitor therapy and requires cautious use in at-risk patients.
  • Regulatory Note: etoricoxib is approved in many countries but not approved in the United States.
  • Clinical Recommendation: consult current systematic reviews, TGA advisories and local society guidelines for osteoarthritis, gout and postoperative analgesia before prescribing long-term therapy.

Alternatives Matrix

PBS-Listed Alternatives Comparison Table

Drug COX Selectivity Typical PBS Dose Common ADRs PBS Subsidy Status Suitability For High CV Risk
Etoricoxib COX-2 selective See indication-specific dosing GI upset, headache, oedema, BP elevation Check PBS schedule Use with caution; generally less suitable for high CV risk
Celecoxib COX-2 selective Varies by indication Similar to etoricoxib Check PBS schedule Use with caution in high CV risk
Naproxen Non-selective (preferential COX-1/2) Varies by indication GI risk, renal effects Check PBS schedule May be preferred in some CV-protection strategies but has higher GI risk
Ibuprofen Non-selective Varies by indication GI upset, renal effects Check PBS schedule Not preferred in high CV risk
Diclofenac Non-selective Varies by indication GI, hepatic, CV concerns Check PBS schedule Use caution in high CV risk

Pros And Cons Checklist

  • Pros Of Etoricoxib: effective analgesia and anti-inflammatory action; reduced gastric COX-1 inhibition in many patients.
  • Cons Of Etoricoxib: increased cardiovascular risk with long-term or high-dose use; contraindicated in significant hepatic or renal impairment and in pregnancy and children.
  • Alternatives: celecoxib has a similar COX-2 profile; non-selective NSAIDs are often cheaper and more widely subsidised but carry greater GI ulcer risk.
  • Agent Selection Checklist: consider indication, comorbidities, GI and CV risk, PBS access and patient cost.

Common Questions

  • Is Arcoxia Safe For Long-Term Arthritis? Long-term use requires careful consideration of cardiovascular risk, liver and renal function, and regular monitoring; use the lowest effective dose.
  • Can I Take It With Blood Pressure Medicines? Possible interaction with ACE inhibitors, ARBs and diuretics; monitor blood pressure and renal function and discuss with your GP.
  • Is It OK With Aspirin? Do not combine with other NSAIDs; discuss low-dose aspirin for cardioprotection with your prescriber before starting etoricoxib.
  • When To Seek Urgent Care? stop the medicine and seek immediate care for black or tarry stools, sudden chest pain, unexplained shortness of breath or severe skin reactions.
  • Referral Prompt: contact your pharmacist or GP for personalised advice if you have multiple medicines or chronic conditions.

Price And Access Comparison

Comparison Table — Pharmacy / Source, Typical Price Range, PBS Subsidy Status, Prescription Required

Source Typical Price Range (Private) PBS Status Prescription Required
Chemist Warehouse Varies Check PBS schedule Yes
Priceline Varies Check PBS schedule Yes
Community Pharmacy Varies by location Check PBS schedule Yes
Online Australian Pharmacy Varies; shipping may apply Check PBS schedule Yes

Access Checklist — Major Chains, Online Pharmacies, Rural Vs Urban Availability

  • Confirm stock before travel to rural or remote areas.
  • Use e-prescription and telehealth services if GP access is limited.
  • Seek pharmacist advice for dosing, side-effect monitoring and drug interactions.
  • Consider community nursing support for high-risk or housebound patients.
  • Avoid importing medicines from unverified overseas suppliers due to regulatory and authenticity risks.

Registration And Regulation

TGA Approval

Clinicians should verify Arcoxia/etoricoxib ARTG entry for current approval conditions and sponsor details on the TGA website.

Etoricoxib is approved in many countries but is not approved in the United States, which has influenced regulatory labelling differences internationally.

PBS Subsidy Details

PBS listings and authority requirements change periodically.

Check the PBS schedule for current subsidy criteria, restrictions, item numbers and any authority requirements before prescribing if subsidy is required for the patient.

  • Verify ARTG entry and sponsor details.
  • Confirm PBS item number and any authority requirements.
  • Check patient concession eligibility for cost savings.

Storage And Handling

Household Storage In Australian Climate (Heat/Humidity)

  • Store below 30°C and keep in the original blister packaging.
  • Protect tablets from moisture and direct sunlight, especially in hot, humid summers.
  • Do not store in bathrooms or near heating appliances.
  • Keep out of reach of children and animals.

Cold-Chain Handling For Pharmacies

  • No cold chain is required for etoricoxib.
  • Maintain stock rotation and protect stock from prolonged heat exposure during storage and transport.
  • Follow TGA good distribution practice and supplier storage guidance for blister packs.
  • Pharmacy Stock Checklist: temperature logs, inspect damaged packs, check expiry dates regularly.

Guidelines For Proper Use

Australian Pharmacist Counselling Style

  • Confirm the indication and intended duration before supply.
  • Review comorbidities and concurrent medicines for interaction risk.
  • Explain dosing, missed-dose rules and the importance of not doubling doses.
  • Warn about red-flag symptoms such as black stools, chest pain, breathlessness and severe rash.
  • Advise on alcohol avoidance and not combining with other NSAIDs.
  • Arrange follow-up and monitoring of BP, renal function and LFTs as needed.
  • Use teach-back to confirm patient understanding of dosing and warning signs.

Patient Advice From PBS And National Health Authorities

  • Refer patients to PBS factsheets and TGA consumer medicine information for official advice.
  • For chronic therapy, document the clinical rationale and monitoring plan in the patient record.
  • For short-course acute use, ensure the patient knows the maximum recommended duration for their indication.
  • Follow-Up Schedule Checklist: re-evaluate within 1–3 months for high-risk patients, sooner if symptoms develop.
  • Encourage reporting of adverse reactions to the TGA and keeping the GP informed of any new symptoms.

Delivery Across Australia

City Region Delivery Time
Sydney New South Wales 9-14 days
Melbourne Victoria 9-14 days
Brisbane Queensland 9-14 days
Perth Western Australia 9-14 days
Adelaide South Australia 9-14 days
Canberra Australian Capital Territory 9-14 days
Hobart Tasmania 9-14 days
Darwin Northern Territory 9-14 days
Gold Coast Queensland 9-14 days
Newcastle New South Wales 9-14 days
Wollongong New South Wales 14-21 days
Sunshine Coast Queensland 14-21 days
Geelong Victoria 14-21 days
Townsville Queensland 14-21 days
Cairns Queensland 14-21 days

Related products